Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Ovapuldencel-T |
Synonyms | |
Therapy Description |
Ovapuldencel-T is a cancer vaccine consisting of autologous dendritic cells loaded with autologous tumor antigens, which may stimulate anti-tumor immune response (NCI Drug Dictionary). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Ovapuldencel-T | AVOVA-1 | Ovapuldencel-T is a cancer vaccine consisting of autologous dendritic cells loaded with autologous tumor antigens, which may stimulate anti-tumor immune response (NCI Drug Dictionary). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT02033616 | Phase II | Ovapuldencel-T | Autologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens for Treatment of Advanced Epithelial Ovarian Carcinomas | Unknown status | USA | 0 |